All CDMO/CMO operations articles
-
NewsNovel NMR-based method could facilitate safer API manufacturing
The innovative approach for detecting nitrosamine impurities in APIs addresses limitations of traditional mass-based techniques, research says.
-
ArticleEuropean Pharmaceutical Review Issue 1 2026
EPR Issue 1 includes articles on manufacturing, drug delivery, environmental monitoring, analytical techniques and more.
-
ArticleGaelic Labs: Pharma is increasingly focused on supply chain security
General Manager Brian Morrissey discusses his companyâs acquisition of fellow Beta-Lactam manufacturer Athlone Laboratories and its implications for an evolving industry.
-
NewsNeuland Laboratories to open Hyderabad commercial peptide facility
The CDMOâs Module 1 commercial production module is expected to be operational by summer 2026.
-
ReportPharma Horizons: Trends in Pharmaceutical Manufacturing
EPRâs 2026 pharma manufacturing trends report covers the key developments in supply chain, quality, drug development, new modalities and beyond.
-
NewsCharles River Laboratories parts ways with its CDMO business
Aims to further strengthen and broaden its portfolio in order to drive long-term growth, greater efficiency and operational excellence.
-
ArticleThe case for outsourcing water for injection
Essential for any medicine that must be sterile and safe for injection, ROISâ Miguel Ăngel Ortega SĂĄnchez presents the case for outsourcing WFI production to a trusted partner.
-
NewsRecipharm sells manufacturing site to Scinai in biologics collaboration
Recipharm forms a long-term partnership with the Israeli biopharma and CDMO covering early development through to commercial supply.
-
NewsRois appoints Kimberlee Steele as Chief Commercial Officer
She joins the Madrid-headquartered contract development and manufacturing organisation from SHL Medical.
-
ArticleAccelerating consistent, stable cell line development with targeted integration
Experts from WuXi Biologics explain how next-generation cell line development with targeted integration advances the field by enabling the production of clonal cell lines with predictable transgene copies at specific, predefined sites in the host genome.
-
NewsRottendorf and Corealis collaborate on OSD manufacturing
The two CDMOs sign an alliance to offer an integrated early-development offering and accelerated commercial pathway.
-
NewsDr Veit Bergendahl to join Rentschler Biopharma as Chief Operating Officer
New operations lead brings over twenty years of biopharma experience to the CDMOâs Laupheim and Milford sites.
-
NewsFujifilm Biotechnologies inaugurates expanded ÂŁ400m UK biomanufacturing site
The CDMOâs investment in the North-East based site expansion supports UK production of medicines and vaccines.
-
NewsFresenius Kabi and Phlow onshore US epinephrine manufacturing
The collaboration covers the essential medicine's active pharmaceutical ingredients (APIs) and finished doses.
-
NewsVetter Pharma outlines plans for new manufacturing site in Germany
The CDMO is also building a new US aseptic clinical production facility in Illinois as it expands its global footprint.
-
NewsArdena divests SödertÀlje drug substance site to Nanologica
The CDMO and CROâs Swedish API facility will now operate as a Nanologica subsidiary, reverting to its original name Syntagon.
-
NewsSever Pharma Solutions appoints Niklas Lindgren as VP of Quality
He joins the Swedish CDMO from medical device company Dignitana.
-
NewsWuXi Biologics partners with HanchorBio on next-gen immunotherapies
The CRDMO will support the biotech companyâs work on next-generation immunotherapies for oncology and autoimmune diseases.
-
NewsKincell Bio promotes Bruce Thompson to President and Chief Technology Officer
The cell therapy-focused CDMO has also elevated Melodie Bryce to Chief Quality Officer and Matt Haines to Chief Operations Officer.
-
ArticleReiThera on vaccines and remaining nimble around emerging threats
As vaccines are buffeted by political pressures, the CDMO discussed its growth approach and some of its key collaborations.